Effect of cilostazol on in-stent restenosis after carotid artery stenting; Multi-center, prospective, randomized, open-label blind-endpoint trial
Not Applicable
- Conditions
- Carotid Artery Diseases
- Registration Number
- JPRN-UMIN000004705
- Lead Sponsor
- Translational Research Informatics Canter
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 707
Inclusion Criteria
Not provided
Exclusion Criteria
Received endovascular interevention Scheduled for bilateral carotid intervention aortitis or cvasculitis congessive heart failure ischemic stroke within 48 hours hemorrhagic stroke within 90 days renal failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence or absence of in-stent restenosis within 2 yrs after Carotid Artery Stenting and time to occurrence
- Secondary Outcome Measures
Name Time Method